Raquel Miguéis
November 18, 2024

Annual Price Revision for 2025

Portaria n.º 293/2024/1 was published last week, on November 15th, defining the reference countries to be considered for price calculation and the criteria for annual price revision (RAP) of 2025.

The deadlines for RAP 2025 were also defined.

  • For non-generic medicinal products, new maximum prices must be submitted to INFARMED up to 15th December 2024, which will come into force in 1st January 2025.
  • For generic medicinal products, new maximum prices must be submitted to INFARMED up to 15th January 2025, which will come into force in 1st February 2025.

Informative Note and support documentation for RAP 2025 were also published in INFARMED’s website.

Owlpharma can support you in the preparation of Annual Price Revision. For more information, please contact us at owlpharma@owlpharma.pt.

Latest news

November 21, 2024

/

Sofia Santos

Risk Minimisation Measures - GVP Latest Updates

November 18, 2024

/

Raquel Miguéis

Annual Price Revision for 2025

October 4, 2024

/

Eva Faria

Owlpharma's Quality Management System - Certification ISO 9001:2015